Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide

Journal of Cellular Biochemistry

Volumn 89, Issue 4, 2003, Pages 848-861

  Tsukahara, Yasuhiro ^a   Lian, Zheng ^a   Zhang, Xueqing ^b   Whitney, Constance ^b   Kluger, Yuval ^c   Tuck, David ^d   Yamaga, Shigeru ^a   Nakayama, Yasuhiro ^a   Weissman, Sherman M ^a   Newburger, Peter E ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Chemokine; Granulocyte; Interleukin; Microarray; Myeloid; NF kappaB; Toll like receptor; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE ANTIGEN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL INFECTION; CELL ADHESION; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA MICROARRAY; ESCHERICHIA COLI; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; MULTIGENE FAMILY; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

CLUSTER ANALYSIS; ESCHERICHIA COLI; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LIPOPOLYSACCHARIDES; MULTIGENE FAMILY; NEUTROPHIL ACTIVATION; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

BACTERIA (MICROORGANISMS);

EID: 0037636017     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10526     Document Type: Article

References (30)

1. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191.
2. Armant MA, Fenton MJ. 2002. Toll-like receptors: A family of pattern-recognition receptors in mammals. Genome Biol 3:REVIEWS3011.
3. Barroso-Aranda J, Chavez-Chavez RH, Mathison JC, Suematsu M, Schmid-Schonbein GW. 1994. Circulating neutrophil kinetics during tolerance in hemorrhagic shock using bacterial lipopolysaccharide. Am J Physiol 266:H415-H421.
4. Bone RC, Grodzin CJ, Balk RA. 1997. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 112:235-243.
5. Caamano J, Hunter CA. 2002. NF-kappaB family of transcription factors: Central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15:414-429.
6. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SP. 1996. Accessing genetic information with high-density DNA arrays. Science 274:610-614.
7. Condliffe AM, Kitchen E, Chilvers ER. 1998. Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 94:461-471.
8. Dianzani C, Lombardi G, Collino M, Ferrara C, Cassone MC, Fantozzi R. 2001. Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J Leukoc Biol 69:1013-1018.
9. Dong G, Loukinova E, Chen Z, Gangi L, Chanturita TI, Liu ET, Van Waes C. 2001. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. Cancer Res 61:4797-4808.
10. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ, Wilson CB. 2001. Cutting edge: Functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166:15-19.
11. Kaisho T, Akira S. 2002. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589:1-13.
12. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. 2002. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: Cell fate is regulated at the level of gene expression. Proc Natl Acad Sci USA 99:6901-6906.
13. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE, Finberg RW. 2002. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860-1868.
14. Li X, Yang Y, Ashwell JD. 2002. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:345-347.
15. Lian Z, Wang L, Yamaga S, Bonds W, Beazer-Barclay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N, Weissman SM. 2001. Genomic and proteomic analysis of the myeloid differentiation program. Blood 98:513-524.
16. Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, Shah N, Shen N, Yang R, Fodor SP. 1995. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19:442-447.
17. Marie C, Muret J, Fitting C, Losser MR, Payen D, Cavaillon JM. 1998. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91:3439-3446.
18. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. 1993. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91:853-861.
19. Means TK, Golenbock DT, Fenton MJ. 2000. The biology of toll-like receptors. Cytokine Growth Factor Rev 11:219-232.
20. Mollapour E, Linch DC, Roberts PJ. 2001. Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2). Blood 97:2469-2477.
21. Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF. 2002. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 32:3337-3347.
22. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004.
23. Neufert C, Pai RK, Noss EH, Berger M, Boom WH, Harding CV. 2001. Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J Immunol 167:1542-1549.
24. Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, Saban R. 2001. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 5:147-160.
25. Subrahmanyam YV, Baskaran N, Newburger PE, Weissman SM. 1999. A modified method for the display of 3′-end restriction fragments of cDNAs: Molecular profiling of gene expression in neutrophils. Methods Enzymol 303:272-297.
26. Subrahmanyam YV, Yamaga S, Prashar Y, Lee HH, Hoe NP, Kluger Y, Gerstein M, Goguen JD, Newburger PE, Weissman SM. 2001. RNA expression patterns change dramatically in human neutrophils exposed to bacteria. Blood 97:2457-2468.
27. Sweeney JF, Nguyen PK, Omann GM, Hinshaw DB. 1998. Lipopolysaccharide protects polymorphonuclear leukocytes from apoptosis via tyrosine phosphorylation-dependent signal transduction pathways. J Surg Res 74:64-70.
28. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. 1998. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
29. Werneburg BG, Zoog SJ, Dang TT, Kehry MR, Crute JJ. 2001. Molecular characterization of CD40 signaling intermediates. J Biol Chem 276:43334-43342.
30. Zhang G, Ghosh S. 2001. Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13-19.